Using virtual and mixed reality technology with mirror therapy for stroke rehabilitation

Technology-based and Activity-based Design of Mirror Therapy Principles: Two Mixed Reality and Virtual Reality Mirrored-hand Systems for Stroke Rehabilitation

NA · Chang Gung Memorial Hospital · NCT05903235

This study is testing new virtual and mixed reality therapies combined with mirror therapy to see if they can help stroke patients recover their movement better than traditional methods.

Quick facts

PhaseNA
Study typeInterventional
Enrollment45 (estimated)
Ages20 Years to 80 Years
SexAll
SponsorChang Gung Memorial Hospital (other)
Locations1 site (Taoyuan City)
Trial IDNCT05903235 on ClinicalTrials.gov

What this trial studies

This study aims to develop and test virtual reality (VR) and mixed reality (MR) systems combined with mirror therapy (MT) for stroke rehabilitation. Initially, a feasibility study will assess user experiences with these new systems among stroke patients. Following this, a randomized controlled trial will compare the effectiveness of VR+MT and MR+MT against traditional MT in improving motor functions. The study will also identify which patients respond best to these innovative therapies based on their initial motor abilities and mental imagery skills.

Who should consider this trial

Good fit: Ideal candidates are adults aged 20 to 80 who have experienced a unilateral stroke and have a specific range of motor function as measured by the Fugl-Meyer Assessment.

Not a fit: Patients with global or receptive aphasia, severe neglect, or significant comorbidities that affect therapy participation may not benefit from this study.

Why it matters

Potential benefit: If successful, this approach could enhance rehabilitation outcomes for stroke patients by providing more effective therapy options.

How similar studies have performed: While the use of VR and MR in rehabilitation is gaining interest, this specific combination with mirror therapy is relatively novel and has not been extensively tested in prior studies.

Eligibility criteria

Show full inclusion / exclusion criteria
Phase Ⅰ: Design and Development of the VR+MT and MR+MT Systems \& Feasibility Study

Inclusion Criteria:

* diagnosed with unilateral stroke
* age of 20 to 80 years
* a baseline Fugl-Meyer Assessment of the Upper Extremity score of 20 to 60
* able to follow the study instructions and provide the feedback of user experiences verbally

Exclusion Criteria:

* diagnosed with global or receptive aphasia
* the presence of severe neglect
* the existence of major medical problems or comorbidities that could interfere with upper-limb usage and pain, or disrupt visual or auditory perception

Phase Ⅱ: Validation and Comparison of Clinical Treatment Efficacy

Inclusion Criteria:

* diagnosed with unilateral stroke
* more than 6 months after stroke onset
* age of 20 to 80 years
* a baseline Fugl-Meyer Assessment of the Upper Extremity score of 20 to 60
* able to follow the study instructions
* capable of participating in the assessment process and treatment program

Exclusion Criteria:

* diagnosed with global or receptive aphasia
* the presence of severe neglect
* the existence of major medical problems or comorbidities that could interfere with upper-limb usage and pain, or disrupt visual or auditory perception

Where this trial is running

Taoyuan City

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Stroke, Cerebrovascular Disorders, Central Nervous System Diseases, digital rehabilitation, mixed reality, virtual reality, cerebrovascular accident, mirror visual feedback

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.